The University of Miami Hemophilia Treatment Center's 340B Program is a clotting factor related pharmacy that is dedicated to serving the patients of the UM HTC.
The 340B is a federal program that provides clotting factor to patients at significantly reduced prices. Benefits include:
Significantly lower cost of factor concentrate - Lower cost of concentrate lessens the likelihood of reaching lifetime caps on health insurance coverage
Revenues support the treatement center, thereby preserving the high level of care and services provided
Consistent, fair and reduced pricing for all clients
Access to an experienced pharmacist who specializes in the care of patients with bleeding disorders
Access to pharmacy services 24 hours a day/ 7 days a week
Access to all factor products available on the market
Find Out if You Qualify For the 340B Program
Call Patrice at 305-243-6925 and Enroll Right Away!
Copyright 2008, The University of Miami Hemophilia Treatment Center, all rights reserved